Egypt Expands Pharmaceutical Market into Latin America with Insulin Exports to Cuba
Egypt is making strides in the pharmaceutical industry by exporting lifesaving insulin injections to Cuba as part of a new market expansion into Latin America. The Insulinagypt injections, produced in Egypt and used to treat diabetes, will be exported through the United Company for Pharmaceuticals, an affiliate of the ACDIMA group.
Fruitful Cooperation Between Egypt and Cuba
Khaled Abdel Ghaffar, Egypt’s minister of housing, expressed his excitement about this new venture, stating that it marks the beginning of a new phase of fruitful cooperation between the Egyptian state and Cuba. This achievement is significant as it represents the first presence of an Arab-African-Egyptian company supplying Cuba with medicines. The United Company for Pharmaceuticals, led by Dr. Alfat Garab, will act as the Egyptian representative for the pharmaceutical exports to Cuba.
ACDIMA’s Global Reach
Dr. Alfat Garab, the chairperson of ACDIMA, highlighted the company’s global reach, with products distributed in 80 countries worldwide. ACDIMA’s new project aligns with Egypt’s efforts to localize the latest technologies and produce modern products in fields such as oncology, biosimilars, and biologics while adhering to international regulations. The collaboration with Cuba opens doors for potential partnerships with other Latin American countries.
Commitment to Healthcare Access
Ahmed Shawkat, Egypt’s deputy minister of health, emphasized Egypt’s commitment to ensuring access to essential medications like insulin. Egyptian insulin commands a significant market share annually and is exported to 11 African countries. The export of Egyptian insulin to Cuba symbolizes a momentous instance of cooperation between the two countries and underscores the importance of providing lifesaving treatment for individuals with diabetes.
Supporting Global Health Initiatives
Shawkat highlighted Egypt’s dedication to supporting global health initiatives and establishing international cooperation for technology transfer and joint production of medical treatments. This commitment aligns with various presidential campaigns and initiatives aimed at improving healthcare access and advancing medical technologies.
A Testament to Egypt’s Commitment
The opening of the export market for insulin is a testament to Egypt’s unwavering commitment to ensuring basic healthcare for all. By collaborating with Cuba and other Latin American countries, Egypt is not only expanding its pharmaceutical market but also contributing to global health efforts. This partnership serves as a reminder of the importance of supporting each other, especially in times of need.
In conclusion, Egypt’s export of insulin to Cuba represents a significant milestone in the country’s pharmaceutical industry. The collaboration between Egyptian and Cuban companies showcases the potential for international cooperation in providing essential medications and advancing healthcare access worldwide. This initiative underscores Egypt’s commitment to supporting global health initiatives and promoting technological advancements in the medical field.